Trombosis y c芍ncer Thrombosis and cancer

作者：P Salama

来源：Anales del Sistema Sanitario de Navarra, 2004.

• Enfermedad tromboembolica venosa
• Cancer
• Anticoagulacion
• Tratamiento
• Profilaxis
• Venous thromboembolic disease
• Cancer
• Anticoagulation
• Treatment
• Prophylaxis

La enfermedad tromboemb車lica venosa constituye una grave complicaci車n en los pacientes con c芍ncer. Aunque su incidencia no es bien conocida la asociaci車n enfermedad tromboemb車lica venosa-c芍ncer es frecuente y constituye por s赤 misma una urgencia. Ante una cl赤nica compatible con enfermedad tromboemb車lica venosa es imperativo el realizar una historia cl赤nica completa para saber qu谷 tumor padece el enfermo y si tiene factores de riesgo asociados (ser portador de un cat谷ter venoso central, estar en tratamiento con quimioterapia, qu谷 tipo de quimioterapia ha recibido, si ha sido intervenido quir迆rgicamente de su c芍ncer). Posteriormente si tenemos una alta sospecha de enfermedad tromboemb車lica venosa se debe de iniciar el tratamiento sin esperar una confirmaci車n diagn車stica inmediata. El tratamiento en el paciente oncol車gico es similar al del paciente no oncol車gico pero se deben de tener m芍s en cuenta las complicaciones derivadas del tratamiento como la hemorragia, ya que puede empeorar el pron車stico del enfermo. Debido a todo ello, los esfuerzos deben de ir dirigidos a hacer una buena profilaxis antitromb車tica. Venous thromboembolic disease is a serious complication in patients with cancer. Although its incidence is not well known, the association between thromboembolic disease and cancer is frequent and is in itself an emergency. Facing clinical manifestations compatible with thromboembolic disease, it is imperative to elaborate a complete clinical history in order to know which is the tumour the patient is suffering from and if there are associated risk factors (if he is the bearer of a central venous catheter, if he is receiving treatment with chemotherapy, if his cancer has undergone a surgical intervention). Subsequently, if we hold a high suspicion of venous thromboembolic disease, treatment should be started without waiting for an immediate diagnostic confirmation. Treatment in the oncology patient is similar to that in the non-oncology patient, but greater attention should be paid to the complications deriving from the treatment, such as haemorrhaging, since this can worsen the prognosis of the patient. Due to that, efforts should be directed towards a good antithrombotic prophylaxis.